📰 Clinical Program News
Page 10 - Clinical Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Clinical Program. Real-time updates on events, politics, business and more.
October 30, 2023
BioMendics LLC, a pharmaceutical company developing new medicines to improve the lives of patients living with rare skin diseases, today announced its participation in the 7th Annual Dermatology Drug Development Summit for Inflammatory Skin Diseases, taking place from October 31 - November 2 in Boston, Massachusetts.
October 26, 2023
EnVVeno Medical Reports Third Quarter 2023 Financial Results and Provides ...
October 26, 2023
PKP2 Mutations Are the Leading Cause of ARVC, a Dangerous Condition Linked to Sudden Cardiac Arrest in Young People Estimated to Affect 70,000 People in the US TN-401 Preclinical Studies Demonstrated...
October 26, 2023
A research project was recently published by the Journal of Hospital Management and Health Policy, indicating that 60 percent of Washoe County residents (and 74 percent of Washoe County non-smokers) would favor a law prohibiting smoking in all casinos in Washoe County.
October 21, 2023
Cancer Support Community Missoula will hold its Fall Festival at the Missoula County Fairgrounds on Saturday.
October 17, 2023
New pipeline program builds on academic studies of durable, drug-free remissions in patients with autoimmune disease after CD19-targeted cell therapy NKX019, an allogeneic CAR NK cell therapy targeting CD19+ B
October 13, 2023
CAMBRIDGE, Mass., Oct. 13, 2023 -- Intellia Therapeutics, Inc. , a leading clinical-stage genome editing company focused on developing potentially curative therapeutics leveraging CRISPR-based...
October 4, 2023
Experts Reviewed Data from QDENGA’s Clinical Program Across 19 Phase 1, 2 and 3 Trials with More Than 28,000 ParticipantsWHO Will Consider the SAGE Recommendation and Provide Final Guidance on the Use of QDENGA in Public Vaccination Programs in the Coming MonthsDengue Poses a Significant and Growing Public Health Bu...
October 4, 2023
Takeda TSE4502NYSETAK today announced that the World Health Organizations WHO Strategic Advisory Group of Experts SAGE on Immunization shared recommendations for use of QDENGA Dengue Tetravalent Vaccine Live Attenuated TAK003.
September 18, 2023
KT-333 Phase 1 oncology trial ongoing with an update including initial evaluation of its clinical antitumor activity in patients expected in the fourth quarter of 2023 Fast Track designation can...